Study on community care for axial spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new way to manage axial spondyloarthritis using patient-reported outcomes from home, aiming to improve care and reduce hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have axial spondyloarthritis as diagnosed by a doctor using standard criteria.
- You must have been treated at Singapore General Hospital for at least 6 months.
- You must be 21 years or older.
- Your current disease activity score (BASDAI) must be 4 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how axial spondyloarthritis progresses over time in Chinese patients. It helps doctors understand the natural course of the disease and improve care.
This study follows people who were diagnosed with axial spondyloarthritis (axSpA) recently to better understand the condition over time. It’s mainly for adults and teens who can consent and can communicate in English.
This trial tests an investigational medication called SCT650C for people with active axial spondyloarthritis. It aims to see if it can reduce pain and inflammation better than current treatments.
This study looks at people who have just been diagnosed with a type of arthritis that affects the spine (axial spondyloarthritis) and have not yet started treatment. The goal is to understand the disease better.
This trial is testing a new approach to help people with arthritis who are not satisfied with their symptom control. It may be a good fit if you have rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis and are still struggling with fatigue, pain, or how the disease affects your daily life.
This trial tests whether taking nonsteroidal anti-inflammatory drugs (NSAIDs) helps people with axial spondyloarthritis stay in remission and avoid future flare-ups. It’s meant to see if NSAIDs can reduce the chance of symptoms returning and keep disease activity low over time.
Hear when a new Axial Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.